27 Sep 2025
// PRESS RELEASE
03 Sep 2025
// PRESS RELAESE
11 Sep 2024
// PRESS RELEASE
About
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #11.1F56
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #11.1F56
28-30 October, 2025
Industry Trade Show
Not Confirmed
19-22 October, 2025
Industry Trade Show
Not Confirmed
20-22 October, 2025
27 Sep 2025
// PRESS RELEASE
https://www.caymanchem.com/news/advancing-cell-and-gene-therapy-development-with-akadeum-partnership
03 Sep 2025
// PRESS RELAESE
11 Sep 2024
// PRESS RELEASE
https://www.caymanchem.com/news/cabri-announces-fellowship-opportunities-for-undergraduate-research-traineeships
21 Aug 2024
// PRESS RELEASE
https://www.caymanchem.com/news/cayman-and-certest-announce-partnership-expanding-access-to-ionizable-lipids-for-lipid-nanoparticles
05 Jun 2024
// PRESS RELEASE
https://www.caymanchem.com/news/cayman-pcrassays-partnership-expands-molecular-diagnostic-research
02 Feb 2024
// PRESS RELEASE
https://www.caymanchem.com/news/cayman-chemical-introduces-lipidlaunch%E2%84%A2
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-09-10
Pay. Date : 2013-08-16
DMF Number : 17445
Submission : 2004-06-01
Status : Active
Type : II
Certificate Number : CEP 2022-093 - Rev 01
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 2230
Status : Valid
Registration Number : 221MF10182
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2009-08-13
Latest Date of Registration :
Registration Number : 220MF10211
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2008-10-10
Latest Date of Registration :
Registrant Name : Korea Santen Pharmaceutical Co., Ltd.
Registration Date : 2023-11-20
Registration Number : Su139-6-ND
Manufacturer Name : Cayman Chemical Company
Manufacturer Address : 1180 E. Ellsworth Road Ann Arbor, MI 48108 USA
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-10
Pay. Date : 2013-08-16
DMF Number : 17445
Submission : 2004-06-01
Status : Active
Type : II
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
Details:
The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Lead Product(s): KMN-159,Collagen
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Miscellaneous
Sponsor: NIDCR
Deal Size: $1.7 million Upfront Cash: Undisclosed
Deal Type: Funding September 16, 2021
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 16, 2021
Details:
The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Lead Product(s): Undisclosed,Inapplicable
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Undisclosed
Sponsor: SBIR
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Funding October 08, 2020
Lead Product(s) : Undisclosed,Inapplicable
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : SBIR
Deal Size : Undisclosed
Deal Type : Funding
Cayman Receives SBIR Grant for Alzheimer’s Research
Details : The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 08, 2020
Inspections and registrations
ABOUT THIS PAGE
Cayman Chemical Company Inc is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find a price of Latanoprost bulk with DMF, CEP, JDMF offered by Cayman Chemical Company Inc
Find a price of Latanoprost bulk with JDMF offered by Cayman Chemical Company Inc
Find a price of Dimethyltryptamine bulk offered by Cayman Chemical Company Inc
Find a price of Midomafetamine bulk offered by Cayman Chemical Company Inc
Find a price of Netarsudil Mesylate bulk offered by Cayman Chemical Company Inc
Find a price of Psilocin bulk offered by Cayman Chemical Company Inc
Find a price of Retatrutide bulk offered by Cayman Chemical Company Inc